Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Critical Care Pulmonary and Sleep Associates
mi
from
Lakewood, CO
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Critical Care Pulmonary and Sleep Associates
mi
from
Lakewood, CO
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
PAB Clinical Research
mi
from
Brandon, FL
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Broward Research Group
mi
from
Hollywood, FL
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Broward Research Group
mi
from
Hollywood, FL
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Oviedo Medical Research, LLC
mi
from
Oviedo, FL
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Oviedo Medical Research, LLC
mi
from
Oviedo, FL
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Emory Sleep Center
mi
from
Atlanta, GA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Emory Sleep Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Rowe Neurology Institute RNI - Lenexa
mi
from
Lenexa, KA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Rowe Neurology Institute RNI - Lenexa
mi
from
Lenexa, KA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Veritas Clinical Specialities, LTD
mi
from
Topeka, KA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Veritas Clinical Specialities, LTD
mi
from
Topeka, KA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Advanced Neurodiagnostic Ceneter
mi
from
Metairie, LA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Advanced Neurodiagnostic Ceneter
mi
from
Metairie, LA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Brigham and Women's Hosp
mi
from
Boston, MA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Duke Univ Med Ctr
mi
from
Durham, NC
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
PMG Research of Wilmington
mi
from
Wilmington, NC
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Center for Sleep & Circadian Neurobiology
mi
from
Philadelphia, PA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Center for Sleep & Circadian Neurobiology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
UPMC Sleep Medicine Center
mi
from
Pittsburgh, PA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
UPMC Sleep Medicine Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Lowcountry Lung & Critical Care, PA
mi
from
Charleston, SC
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Lowcountry Lung & Critical Care, PA
mi
from
Charleston, SC
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Medical University of South Carolina
mi
from
Charleston, SC
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
EVMS Sleep Medicine
mi
from
Norfolk, VA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
EVMS Sleep Medicine
mi
from
Norfolk, VA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
American Sleep Medicine
mi
from
Vienna, VA
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
American Sleep Medicine
mi
from
Vienna, VA
Click here to add this to my saved trials
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Tampere University Hospital
mi
from
Tampere,
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Tampere University Hospital
mi
from
Tampere,
Click here to add this to my saved trials
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation for Patients With Acute Respiratory Failure: A Randomized, Double-blind, Placebo-controlled Pilot Study
Status: Enrolling
Updated:  11/20/2017
Tufts Medical Center
mi
from
Boston, MA
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation for Patients With Acute Respiratory Failure: A Randomized, Double-blind, Placebo-controlled Pilot Study
Status: Enrolling
Updated: 11/20/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation for Patients With Acute Respiratory Failure: A Randomized, Double-blind, Placebo-controlled Pilot Study
Status: Enrolling
Updated:  11/20/2017
Winchester Hospital
mi
from
Winchester, MA
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation for Patients With Acute Respiratory Failure: A Randomized, Double-blind, Placebo-controlled Pilot Study
Status: Enrolling
Updated: 11/20/2017
Winchester Hospital
mi
from
Winchester, MA
Click here to add this to my saved trials
An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
Status: Enrolling
Updated:  11/21/2017
Penn State College of Medicine, Milton S. Hershey Medical Center
mi
from
Hershey, PA
An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
Status: Enrolling
Updated: 11/21/2017
Penn State College of Medicine, Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial
Status: Enrolling
Updated:  11/21/2017
Northwestern University
mi
from
Chicago, IL
Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial
Status: Enrolling
Updated: 11/21/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial
Status: Enrolling
Updated:  11/21/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial
Status: Enrolling
Updated: 11/21/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous and Inhalation Implantation of Autologous Adipose-Derived Stromal Vascular Fraction Cells in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  11/21/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous and Inhalation Implantation of Autologous Adipose-Derived Stromal Vascular Fraction Cells in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 11/21/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Click here to add this to my saved trials
Brain Function and Structure in Cocaine Dependence
Brain Function and Structure in Cocaine Dependence
Status: Enrolling
Updated:  11/21/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Brain Function and Structure in Cocaine Dependence
Brain Function and Structure in Cocaine Dependence
Status: Enrolling
Updated: 11/21/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Status: Enrolling
Updated:  11/21/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Status: Enrolling
Updated: 11/21/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
Effect of a Medicated Topical Therapy, Petrolatum, and No Treatment on Nocturnal Cough and Congestion for Children With Upper Respiratory Infections
Status: Enrolling
Updated:  11/21/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
Effect of a Medicated Topical Therapy, Petrolatum, and No Treatment on Nocturnal Cough and Congestion for Children With Upper Respiratory Infections
Status: Enrolling
Updated: 11/21/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Inspiratory Muscle Strength Training for Sleep-related Breathing Disorders
Respiratory Strength Training Mitigates Hypertension and Sleep Fragmentation in Obstructive Sleep Apnea
Status: Enrolling
Updated:  11/27/2017
Department of Physiology at the University of Arizona
mi
from
Tucson, AZ
Inspiratory Muscle Strength Training for Sleep-related Breathing Disorders
Respiratory Strength Training Mitigates Hypertension and Sleep Fragmentation in Obstructive Sleep Apnea
Status: Enrolling
Updated: 11/27/2017
Department of Physiology at the University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse
Pharmacogenetic Trial of Noradrenergic Medication for Treatment of Cocaine Abuse
Status: Enrolling
Updated:  11/28/2017
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse
Pharmacogenetic Trial of Noradrenergic Medication for Treatment of Cocaine Abuse
Status: Enrolling
Updated: 11/28/2017
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated:  11/29/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated: 11/29/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated:  11/29/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated: 11/29/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated:  11/29/2017
Loyola University Medical Center
mi
from
Maywood, IL
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated: 11/29/2017
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated:  11/29/2017
Indiana University School of Medicine
mi
from
Indianapolis, IN
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated: 11/29/2017
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated:  11/29/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated: 11/29/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated:  11/29/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated: 11/29/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated:  11/29/2017
The Ohio State University College of Medicine
mi
from
Columbus, OH
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated: 11/29/2017
The Ohio State University College of Medicine
mi
from
Columbus, OH
Click here to add this to my saved trials
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated:  11/29/2017
Wisconsin Medical Center
mi
from
Milwaukee, WI
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel
Status: Enrolling
Updated: 11/29/2017
Wisconsin Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Andalusia, AL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Andalusia, AL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Anniston, AL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Anniston, AL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Jasper, AL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Jasper, AL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tempe, AZ
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tempe, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tucson, AZ
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tucson, AZ
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Fayetteville, AR
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Huntington Beach, CA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Rancho Mirage, CA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Colorado Springs, CO
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Altamonte Springs, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Deland, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Deland, FL
Click here to add this to my saved trials